✦ LIBER ✦

Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control

✍ Scribed by Petrongari, Maria; Landoni, Valeria; Saracino, Biancamaria; Gomellini, Sara; Arcangeli, Stefano; Iaccarino, Giuseppe; Pinnarò, Paola; Arcangeli, Giorgio; Strigari, Lidia

Book ID: 121584455
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 240 KB
Volume: 32
Category: Article
ISSN: 1756-9966
DOI: 10.1186/1756-9966-32-103

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-Dose Radiotherapy With or Without A

High-Dose Radiotherapy With or Without Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer: Cancer Control and Toxicity Outcomes

✍ Scott Edelman; Stanley L. Liauw; Peter J. Rossi; Sherrie Cooper; Ashesh B. Jani 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 340 KB

The addition of low-dose-rate brachyther

The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer

✍ Mark Shilkrut; Gregory S. Merrick; P. William McLaughlin; Matthew H. Stenmark; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

105 oral Analysis of acute and late morb

105 oral Analysis of acute and late morbidity, and biochemical control for intermediate to high risk prostate cancer treated with androgen deprivation, HDR and 3D/IMRT: 4 year results of a phase I-II dose escalation trial

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 239 KB

297 poster Dose escalation by HDR brachy

297 poster Dose escalation by HDR brachytherapy in intermediate or high risk localized prostate cancer: early toxicity and biochemical outcome of a pilot study

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Long-term vs. Short-term Androgen Depriv

Long-term vs. Short-term Androgen Deprivation Combined with High-dose Radiotherapy for Intermediate and High-risk Prostate Cancer: Preliminary Results of a GICOR Phase III Randomized Trial

✍ A. Zapatero; A. Guerrero; X. Maldonado; A. Alvarez; A. Cabeza; C. Gonzalez San S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

1095 Analysis of acute and late morbidit

1095 Analysis of acute and late morbidity and biochemical control for intermediate to high risk prostrate cancer treated with androgen deprivation, HDR and 3D/IMRT: update of a phase I–II dose escalation trial

✍ Raben, A.; Grebler, A.; Geltzeiler, J.; Hanlon, A.; Keselman, I.; Litvin, S.; Si 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 158 KB